Horizon Discovery Ltd. And AstraZeneca PLC Win “Licensing Deal Of The Year” At Scrip Awards 2013
CAMBRIDGE--(BUSINESS WIRE)--Horizon Discovery (Horizon) has won “Licensing Deal of the Year” at the Scrip Awards 2013, for their agreement with AstraZeneca to explore Horizon’s first-in-class kinase target program HD-001 as a means of developing novel therapies for multiple cancer types. The Scrip Awards are highly prestigious, recognizing excellence in both pharma and biotech companies and those firms that support them.
Help employers find you! Check out all the jobs and post your resume.